1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
New Interventions for Global Health: Vaccine Manufacturing is sponsored by Bill & Melinda Gates Foundation. This Grand Challenges initiative focuses on innovations in vaccine manufacturing platforms designed to lower production cost for vaccines that target diseases of great global burden and that are among the most costly to produce with current technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Bill & Melinda Gates Foundation Announces New Global Health Grants The Bill & Melinda Gates Foundation Announces New Global Health Grants Bill & Melinda Gates Foundation HYDERABAD, India -- On World TB Day, the Bill & Melinda Gates Foundation announced a series of health-related grants designed to increase access to advances in medical science, particularly for women and children in the developing world.
The grants total more than $133 million, and benefit some of the most vulnerable segments of the world's population including children, refugees, expectant mothers and women, many of whom are shouldering an increased share of the global disease burden.
"Advances in medical science combined with improved nutrition and expanded access to life- saving vaccines have resulted in longer, healthier lives in the United States and across the globe," said Patty Stonesifer, Co-chair and President of the Bill & Melinda Gates Foundation. "At the same time, a troubling gap is widening between the health status of the world's rich and poor.
Closing this gap and improving the health of women and children in the developing world are the overriding goals of the Foundation's Global Health Program." "Tuberculosis has become an even deadlier disease because many strains have developed resistance to most or all of the available drug treatments," said Gordon W. Perkin, M.
D. , Director of the Foundation's Global Health Program. "The Global Alliance for Tuberculosis Drug Development offers hope that the global community will be successful in controlling this ever growing public health threat."
Global Alliance for Tuberculosis Drug Development - $25 Million The newly-formed Global Alliance for TB Drug Development received a $25 million grant to support the development of new therapeutic agents and provide resources to demonstrate the drug's efficacy in clinical trials.
The new Global Alliance will include foundations, pharmaceutical companies and international organizations that are working toward finding new effective treatments for tuberculosis. Save the Children - $50 Million Save the Children, one of the world's largest private, nonprofit children's development and relief organizations, received a $50 million, five-year grant to help save the lives of newborn children worldwide.
The grant will support a global Saving Newborn Lives initiative to increase access to low-cost technologies to substantially reduce the estimated 5. 4 million annual deaths of newborns. The Foundation award represents the largest private grant to Save the Children in its 68-year history.
For more information about Save the Children, visit their website. The Infectious Disease Research Institute - $15 Million The Infectious Disease Research Institute received a $15 million grant to fund their ongoing effort to develop a vaccine to prevent leishmaniasis, a skin and visceral disease endemic in Southern Asia, particularly in India, Africa, South America and the Middle East.
The Institute will work closely with Corixa, a biotechnology company. According to the World Health Organization (WHO), leishmaniasis causes approximately half a million deaths annually. An estimated 15 million new cases of the disease occur each year.
Medicines for Malaria Venture - $25 Million Medicines for Malaria Venture (MMV) received a grant of $25 million, which will support the organization's goal of establishing a public-private partnership to tackle this major global disease. MMV's purpose is to promote the discovery and development of anti-malarial drugs through the investment of public sector funds for drug development.
MMV hopes to register one new anti-malarial drug every five years starting in 2010. For more information about the Medicines for Malaria Venture, visit the website. Albert B.
Sabin Vaccine Institute - $18 Million The Sabin Vaccine Institute received a grant of $18 million to work in partnership with the Medical Helminthology Laboratory at Yale University on the development of a hookworm vaccine. The vaccine will be used alongside more traditional methods and medications to reduce hookworm infection, one of the main causes of anemia and malnutrition worldwide.
For more information about The Sabin Vaccine Institute, visit the website. The Foundation's Global Health Program focuses on three areas: Vaccine-Preventable Diseases; Reproductive and Child Health; and Conditions Associated with Poverty. Please enter a valid email address Invalid Recaptcha, Please try again
According to the current listing, eligibility includes: Investigators in low- and middle-income countries are eligible, and partnerships with investigators in other countries are encouraged, especially where existing collaborations can be built upon. Confirm the full requirements in the official notice before applying.
The current listing shows up to $10,000,000 over 4 years (Pilot awards up to $2,000,000 over 4 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
New Interventions for Global Health: Vaccine Manufacturing is funded by Bill & Melinda Gates Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
MacKenzie Scott's Yield Giving has moved more than $26 billion — including roughly $7 billion in 2025, over a third of all U.S. megagifts — through unrestricted, trust-based grants with no application. Melinda French Gates's Pivotal Ventures has committed $2 billion to women's health and economic power. The Bezos philanthropies have moved billions more. As the Buffett–Gates era winds down, this new class of megadonor is rewriting the rules of major giving. Here is what changes for nonprofits, and how to become the kind of organization this money finds.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleGates committed $540.2 million over a decade to the Institute for Health Metrics and Evaluation — the largest gift in University of Washington history — while IHME's federal grant income falls from $7.3 million to a projected $4.8 million. The gift is a case study in the anchor-funder model: what it can do that federal money cannot, and the concentration risk it quietly underwrites.
Read article